StonvexLoading…
StonvexStonvexStonvexCore line items from CNH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $15.35B | $17.06B | $22.08B | $21.54B |
Operating Income | $620.00M | $1.46B | $2.70B | $2.68B |
Net Income | $510.00M | $1.25B | $2.27B | $2.03B |
EPS (Diluted) | $0.41 | $0.99 | $1.69 | $1.49 |
Total Assets | $42.75B | $42.93B | $46.27B | $39.38B |
Total Liabilities | $34.92B | $35.16B | $38.12B | $32.41B |
Cash & Equivalents | $2.58B | $3.19B | $4.32B | $4.38B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 1.24B | 1.25B | 1.29B | 1.34B |